These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 7586159

  • 1. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.
    Said TK, Luo L, Medina D.
    Carcinogenesis; 1995 Oct; 16(10):2507-13. PubMed ID: 7586159
    [Abstract] [Full Text] [Related]

  • 2. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK, Moraes RC, Singh U, Kittrell FS, Medina D.
    Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
    [Abstract] [Full Text] [Related]

  • 3. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK, Medina D.
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [Abstract] [Full Text] [Related]

  • 4. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ, Sarcevic B, Sutherland RL, Musgrove EA.
    Oncogene; 1997 Mar 20; 14(11):1329-40. PubMed ID: 9178893
    [Abstract] [Full Text] [Related]

  • 5. Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development.
    Said TK, Medina D.
    Carcinogenesis; 1995 Apr 20; 16(4):823-30. PubMed ID: 7728962
    [Abstract] [Full Text] [Related]

  • 6. Tyrosine phosphorylation in mouse mammary hyperplasias.
    Said TK, Medina D.
    Carcinogenesis; 1995 Apr 20; 16(4):923-30. PubMed ID: 7728975
    [Abstract] [Full Text] [Related]

  • 7. Immortal, non-tumourigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase.
    Said TK, Bonnette S, Medina D.
    Cell Prolif; 1996 Nov 20; 29(11):623-39. PubMed ID: 9105418
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV.
    Exp Cell Res; 2001 Apr 15; 265(1):152-66. PubMed ID: 11281653
    [Abstract] [Full Text] [Related]

  • 9. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.
    Muraoka RS, Lenferink AE, Law B, Hamilton E, Brantley DM, Roebuck LR, Arteaga CL.
    Mol Cell Biol; 2002 Apr 15; 22(7):2204-19. PubMed ID: 11884607
    [Abstract] [Full Text] [Related]

  • 10. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
    Schmidt BA, Rose A, Steinhoff C, Strohmeyer T, Hartmann M, Ackermann R.
    Cancer Res; 2001 May 15; 61(10):4214-21. PubMed ID: 11358847
    [Abstract] [Full Text] [Related]

  • 11. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation.
    Chen B, Pollard JW.
    Mol Endocrinol; 2003 Jul 15; 17(7):1368-81. PubMed ID: 12649329
    [Abstract] [Full Text] [Related]

  • 12. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N, Wu WW, Kabra N, Wu X, Lees E, Howard MC.
    J Exp Med; 1996 Aug 01; 184(2):407-17. PubMed ID: 8760794
    [Abstract] [Full Text] [Related]

  • 13. Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development.
    Kong G, Chua SS, Yijun Y, Kittrell F, Moraes RC, Medina D, Said TK.
    Oncogene; 2002 Oct 17; 21(47):7214-25. PubMed ID: 12370811
    [Abstract] [Full Text] [Related]

  • 14. Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors.
    Sgambato A, Han EK, Zhang YJ, Moon RC, Santella RM, Weinstein IB.
    Carcinogenesis; 1995 Sep 17; 16(9):2193-8. PubMed ID: 7554074
    [Abstract] [Full Text] [Related]

  • 15. Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Qiu C, Shan L, Yu M, Snyderwine EG.
    Cancer Res; 2003 Sep 15; 63(18):5674-8. PubMed ID: 14522882
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
    Williamson EA, Burgess GS, Eder P, Litz-Jackson S, Boswell HS.
    Leukemia; 1997 Jan 15; 11(1):73-85. PubMed ID: 9001421
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
    Weroha SJ, Li SA, Tawfik O, Li JJ.
    Carcinogenesis; 2006 Mar 15; 27(3):491-8. PubMed ID: 16311245
    [Abstract] [Full Text] [Related]

  • 20. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
    Sweeney KJ, Swarbrick A, Sutherland RL, Musgrove EA.
    Oncogene; 1998 Jun 04; 16(22):2865-78. PubMed ID: 9671407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.